Splenomegaly
📧 Sign up to get email alerts when something new happens for Splenomegaly.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-08EMA Authorised: Omjjara (Momelotinib dihydrochloride monohydrate) — GlaxoSmithKline Trading Services Limited
EMA authorises Omjjara (momelotinib dihydrochloride monohydrate) for myeloproliferative disorders with splenomegaly; orphan medicine status.
-
EMA approval · 2025-05-12EMA Authorised: Omjjara (Momelotinib dihydrochloride monohydrate) — GlaxoSmithKline Trading Services Limited
The European Medicines Agency authorized Omjjara (momelotinib dihydrochloride monohydrate) for myeloproliferative disorders including myelof…